Brief: China Regenerative Medicine International Posts Loss For Year Attributable Hk$404.6 Million
31/03/2020 24:18
March 31 (Reuters) - China Regenerative Medicine
International Ltd 8158.HK :
* LOSS FOR YEAR ATTRIBUTABLE HK$404.6 MILLION VERSUS LOSS OF
HK$1.19 BILLION
Source text for Eikon: urn:newsml:reuters.com:*:nHKS7zpy9h
Further company coverage: 8158.HK
(Reuters.Briefs@thomsonreuters.com)
Recent news on China Regenerative Medicine International
See all newsBrief: China Regenerative Medicine International Expects FY Profit To Increase At Least 28%
Brief: China Regenerative Medicine International Says Yan Shibin Will Be Appointed As CFO
Brief: China Regenerative Medicine International Posts H1 Revenue Of HKD59.78 Mln
Brief: China Regenerative Medicine International Posts FY Loss Attributable HK$107.7 Mln
Brief: China Regenerative Medicine International Says Subscription Of Increased Registered Capital